Teva Pharm to market medical cannabis inhaler in Israel
Monday, 28 November 2016
JERUSALEM (Reuters) - Israel's Teva Pharmaceuticals has partnered with Tel Aviv-based Syqe Medical to market in Israel medical cannabis for pain management that is administered with an inhaler.
Video: Diversity a top concern for Maryland Medical Cannabis Commission 02:09
Maryland's Medical Cannabis Commission announced on Monday that it is hiring a diversity consultant.
You Might Like
Other recent news in Health